-
- Fellowship
- Posted 2 months ago
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 11 months ago
Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
at National Institutes of Health in États-Unis -
- Fellowship
- Posted 11 months ago
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R41/R42 Clinical Trial Optional)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Intent to Publish a Funding Opportunity Announcement for Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (R43/R44 Clinical Trial Optional)
at National Institutes of Health in États-Unis -
- Research/Project Funding Opportunity
- Posted 2 years ago
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
at Department of Health and Human Services National Institutes of Health in États-Unis